Irritable Bowel Syndrome Channel
Topics & Medications
Related Channels

Zelnorm Dosage

Zelnorm Dosing for Chronic Idiopathic Constipation

For the treatment of chronic idiopathic constipation in people less than 65 years old, the suggested dose is Zelnorm 6 mg taken by mouth twice daily before meals. Your healthcare provider will decide if you need to stay on Zelnorm long-term.

General Zelnorm Dosage Information

Some considerations for people taking Zelnorm include:
  • Zelnorm has not been approved for IBS with constipation in men or for chronic idiopathic constipation in people 65 years of age or older.
  • Zelnorm should be taken at the same time each day to maintain an even level of the medicine in your blood.
  • If you do not take your Zelnorm as scheduled, take your next dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose of Zelnorm.
  • Your Zelnorm dosage should be taken before meals and on an empty stomach if possible. Try to space your Zelnorm doses out evenly, perhaps one dose before breakfast and the second dose before your evening meal.
  • For Zelnorm to work properly, you have to take it as prescribed. Zelnorm will not work if you take it in a way other than how your healthcare provider has prescribed. If you stop taking Zelnorm, IBS or chronic constipation symptoms may return in one or two weeks.
  • If you are unsure about anything related to Zelnorm or your Zelnorm dosage, please talk to your doctor, nurse, or pharmacist. Do not stop taking Zelnorm without first discussing it with your healthcare provider.

Zelnorm Information

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2018 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.